B. Jelassi

Understanding the roles of the P2X7 receptor in solid tumour progression and therapeutic perspectives.

P. Pelegrín, Lin-Hua Jiang, I. Couillin, 2015, Biochimica et biophysica acta.

Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors.

M. Cayuela, Lin-Hua Jiang, J. Goré, 2013, Carcinogenesis.

P2X7 receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness

M. Cayuela, A. Surprenant, P. Pelegrín, 2011, Oncogene.

P2X7 Receptor Promotes Mouse Mammary Cancer Cell Invasiveness and Tumour Progression, and Is a Target for Anticancer Treatment

A. le Pape, S. Lerondel, Lin-Hua Jiang, 2020, Cancers.

The activation of P2Y2 receptors increases MCF-7 breast cancer cells migration through the MEK-ERK1/2 signalling pathway.

D. Angoulvant, S. Roger, P. Besson, 2014, Carcinogenesis.